JPH05504957A - 療法―抵抗性精神分裂症治療用医薬 - Google Patents
療法―抵抗性精神分裂症治療用医薬Info
- Publication number
- JPH05504957A JPH05504957A JP3505335A JP50533591A JPH05504957A JP H05504957 A JPH05504957 A JP H05504957A JP 3505335 A JP3505335 A JP 3505335A JP 50533591 A JP50533591 A JP 50533591A JP H05504957 A JPH05504957 A JP H05504957A
- Authority
- JP
- Japan
- Prior art keywords
- treatment
- schizophrenia
- therapy
- patients
- resistant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (3)
- 1.療法−抵抗性精神分裂症の治療用の医薬の製造に対するアンペロジド、すな わち、式 ▲数式、化学式、表等があります▼ のN−エチル−4−〔4′,4′−ビス(p−フルオロフェニル)ブチル〕−ピ ペラジン−カルボキサミドまたはその許容し得る酸塩の使用。
- 2.アンペロジドを医薬的に許容し得る担体中に分散した請求項1記載の使用。
- 3.医薬が1日当り約1〜50mgの量でアンペロジドを含有する請求項1記載 の使用。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/487,547 US5013735A (en) | 1990-03-01 | 1990-03-01 | Method of treating therapy-resistant schizophrenia with amperozide (N-ethyl-4-(4',4'-bis(p-fluorophenyl)butyl)-1-piperazine-carboxamide |
US487,547 | 1990-03-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH05504957A true JPH05504957A (ja) | 1993-07-29 |
JP3243514B2 JP3243514B2 (ja) | 2002-01-07 |
Family
ID=23936183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50533591A Expired - Fee Related JP3243514B2 (ja) | 1990-03-01 | 1991-02-27 | 療法―抵抗性精神分裂症治療用医薬 |
Country Status (8)
Country | Link |
---|---|
US (1) | US5013735A (ja) |
EP (1) | EP0517787B1 (ja) |
JP (1) | JP3243514B2 (ja) |
AT (1) | ATE167398T1 (ja) |
DE (1) | DE69129623T2 (ja) |
DK (1) | DK0517787T3 (ja) |
ES (1) | ES2117008T3 (ja) |
WO (1) | WO1991012805A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5300422A (en) * | 1991-12-04 | 1994-04-05 | Case Western Reserve University | Screening method for controlling agranulocytosis |
GB0306604D0 (en) * | 2003-03-21 | 2003-04-30 | Curidium Ltd | Second medical use |
US20080076924A1 (en) * | 2006-06-30 | 2008-03-27 | Patrick Betschmann | Piperazines as P2X7 antagonists |
US20080139573A1 (en) * | 2006-12-08 | 2008-06-12 | Copharm | Treatment of resistant Schizophrenia and other CNS disorders |
JP7321114B2 (ja) * | 2019-04-26 | 2023-08-04 | ユニ・チャーム株式会社 | 吸収性物品用の流動体の配置方法及び吸収性物品 |
-
1990
- 1990-03-01 US US07/487,547 patent/US5013735A/en not_active Expired - Lifetime
-
1991
- 1991-02-27 EP EP91905529A patent/EP0517787B1/en not_active Expired - Lifetime
- 1991-02-27 DE DE69129623T patent/DE69129623T2/de not_active Expired - Fee Related
- 1991-02-27 JP JP50533591A patent/JP3243514B2/ja not_active Expired - Fee Related
- 1991-02-27 ES ES91905529T patent/ES2117008T3/es not_active Expired - Lifetime
- 1991-02-27 DK DK91905529T patent/DK0517787T3/da active
- 1991-02-27 WO PCT/SE1991/000161 patent/WO1991012805A1/en active IP Right Grant
- 1991-02-27 AT AT91905529T patent/ATE167398T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1991012805A1 (en) | 1991-09-05 |
DE69129623D1 (de) | 1998-07-23 |
EP0517787B1 (en) | 1998-06-17 |
US5013735A (en) | 1991-05-07 |
JP3243514B2 (ja) | 2002-01-07 |
ATE167398T1 (de) | 1998-07-15 |
EP0517787A1 (en) | 1992-12-16 |
DE69129623T2 (de) | 1998-12-17 |
DK0517787T3 (da) | 1999-04-06 |
ES2117008T3 (es) | 1998-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6395788B1 (en) | Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine | |
Lieberman | Maximizing clozapine therapy: managing side effects | |
Acri et al. | Effects of risperidone in overdose | |
JPH0757727B2 (ja) | 抑うつ障害の治療用に適した制御放出製薬組成物 | |
CA2294589A1 (en) | Composition for controlling mood disorders in healthy individuals | |
CA3161244A1 (en) | Treatment of amyotrophic lateral sclerosis | |
MX2007000713A (es) | Memantina como tratamiento adyuntivo con antipsicoticos atipicos en pacientes con esquizofrenia. | |
Citrome | Paliperidone: quo vadis? | |
JPS59193821A (ja) | 抗不安薬としてのフルオキセチンの使用法 | |
RU2268725C2 (ru) | Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных расстройств | |
WO1993021917A1 (en) | Dopamine and noradrenergic reuptake inhibitors in treatment of schizophrenia | |
CN110958879A (zh) | 玛沃谷兰在减少可卡因使用或预防复用可卡因中的用途 | |
JPH05504957A (ja) | 療法―抵抗性精神分裂症治療用医薬 | |
JP2001510800A (ja) | 注意欠損/活動亢進症の治療のためのアルカノイルカルニチン誘導体の使用 | |
WO2023186827A1 (en) | 5-methoxy-n,n-dimethyltryptamine for the treatment of postpartum depression | |
AU2004260624A1 (en) | Use of 3,7-diazabicyclo`3, 3,1 !nonane compounds for the treatment and/or prophylaxis of anti-arrhythmic events in male human patients | |
WO2023186806A1 (en) | 5-methoxy-n,n-dimethyltryptamine for the treatment of bipolar disorder | |
Gallant | Antidepressant overdose: symptoms and treatment | |
WO2024145288A2 (en) | Methods of administering r-ketamine | |
JPH04159224A (ja) | ヒトの糖尿病性知覚障害および末梢神経障害の治療剤 | |
Kudo | Clinical effectiveness off KB-831 on depression with once or twice daily dosage regimen | |
US20050054667A1 (en) | Method of treating or inhibiting anti-arrhythmic events in male human patients | |
Kuznar | Clinical updates review findings on long-acting levomilnacipran in major depressive disorder, depot versus oral antipsychotics for schizophrenia. | |
SPLETE | Two New Weight Loss Drugs Show Potential | |
MX2007008323A (es) | Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente benzodiazepinico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071026 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081026 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081026 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091026 Year of fee payment: 8 |
|
LAPS | Cancellation because of no payment of annual fees |